Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2012
05/29/2012US8187607 Hapten-carrier conjugates and uses thereof
05/29/2012US8187590 Probiotic, lactic acid-producing bacteria and uses thereof
05/29/2012US8187588 Mycoplasma hyopneumoniae bacterin vaccine
05/29/2012US8187581 Copolymers from acryloyldimethyltaurine or an acryloyldimethyltaurate, olefinically unsaturated, noncationic, crosslinking comonomer, olefinically unsaturated, cationic comonomer having oxygen, nitrogen, sulfur or phosphorus, silicon-containing component, macromonomer having oxygen, nitrogen, sulfur
05/29/2012CA2709967C Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof
05/29/2012CA2583876C A transmucosal veterinary composition comprising detomidine
05/29/2012CA2557910C Methods of reducing aggregation of il-1ra
05/29/2012CA2554751C Anti-inflammatory analgesic for external use
05/29/2012CA2534241C Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers
05/29/2012CA2529561C Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
05/29/2012CA2520522C Cladribine formulations for improved oral and transmucosal delivery
05/29/2012CA2516056C Aprotinin and analogs as carriers across the blood-brain barrier
05/29/2012CA2512487C Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
05/29/2012CA2502219C A process for producing an amorphous isomer of lansoprazole
05/29/2012CA2496127C Piperidinyl compounds that selectively bind integrins
05/29/2012CA2483282C Polymeric microemulsions
05/29/2012CA2483214C Wound dressings comprising hydrated hydrogels and enzymes
05/29/2012CA2482499C Aerosol containing a particulate active substance
05/29/2012CA2469623C Composition for the preservation of viruses
05/29/2012CA2448218C Sustained release formulation
05/29/2012CA2446738C Abuse-resistant opioid dosage form
05/29/2012CA2441597C Elongated and multiple spacers in activatible prodrugs
05/29/2012CA2417389C Therapeutic polyesters and polyamides
05/29/2012CA2321596C Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
05/24/2012WO2012068476A2 Poly(vinyl benzoate) nanoparticles for molecular delivery
05/24/2012WO2012068376A2 Keratin compositions for treatment of bone deficiency or injury
05/24/2012WO2012068147A1 Controlled release mucoadhesive systems
05/24/2012WO2012068076A2 Pharmaceutical formulations containing soluble drugs
05/24/2012WO2012067947A1 Lipoyl compounds and their use for treating ischemic injury
05/24/2012WO2012067868A2 Coloring composition containing l-dopa and l-arginine and forming a non-covalent derivatization complex
05/24/2012WO2012067592A1 A ready to use clove oil formulation for anesthesia for aquatic animals
05/24/2012WO2012067138A1 Novel polymer derivative of cytidine metabolism antagonist
05/24/2012WO2012066896A1 Combined pharmaceutical preparation
05/24/2012WO2012066581A1 Novel conjugates for targeted drug delivery
05/24/2012WO2012066401A1 Stable oral pharmaceutical compositions of montelukast
05/24/2012WO2012066195A1 Method for preparing amide-initiated polymers having a varied architecture
05/24/2012WO2012066171A1 Nanoparticles for the prevention and/or treatment of diseases of the mucus membranes
05/24/2012WO2012066117A1 Polymeric conjugates of active principles, their process of preparation and their polymeric intermediates
05/24/2012WO2012066086A1 PHARMACEUTICAL FORMULATION COMPRISING INSULIN GLARGINE AND SULFOBUTYL ETHER 7-ß-CYCLODEXTRIN
05/24/2012WO2012065996A1 PHARMACEUTICAL FORMULATION COMPRISING INSULIN GLARGINE AND MALTOSYL-ß-CYCLODEXTRIN
05/24/2012WO2012065751A1 Bio-functionalized stimulus-responsive dissolvable peg-hydrogels
05/24/2012WO2012024233A3 Zwitterionic lipids
05/24/2012WO2012015681A3 Drug-ligand conjugates, synthesis thereof, and intermediates thereto
05/24/2012WO2012011693A3 Cationic lipid, a production method for the same and a vehicle having cell penetrating properties comprising the same
05/24/2012WO2012008779A3 A liquid formulation of long-acting human growth hormone conjugate
05/24/2012WO2012007570A3 New formulations of 14-epi-analogues of vitamin d
05/24/2012WO2012006101A3 Blood substitutes and uses thereof
05/24/2012WO2012001083A3 Novel eprinomectin injectable compositions
05/24/2012WO2011150284A3 Removal of serine proteases by treatment with finely divided silicon dioxide
05/24/2012WO2011119288A3 Multilayer melt-extruded film
05/24/2012WO2011086093A3 Pharmaceutical compositions for oral administration of insulin peptides
05/24/2012US20120130482 Vascular stents
05/24/2012US20120129957 Analyzing the fmr1 gene
05/24/2012US20120129954 Carboxymethylcellulose polyethylene glycol compositions for medical uses
05/24/2012US20120129953 Tingling and salivating compositions
05/24/2012US20120129952 Non-caking salt composition, preparation process and use thereof
05/24/2012US20120129951 Palatable Suspending Vehicle for Pharmaceutical Ingredients
05/24/2012US20120129919 Polycationic amphiphilic cyclooligosaccharides and the use thereof as molecular transporters
05/24/2012US20120128964 Azeotrope-like compositions comprising 1-chloro-3,3,3-trifluoropropene
05/24/2012US20120128799 Soft Dried Marshmallow and Method of Preparation
05/24/2012US20120128782 Multicomponent Degradable Cationic Polymers
05/24/2012US20120128781 Functionalization of nanoparticles by glucosamine derivatives
05/24/2012US20120128779 Process for producing protein microparticles
05/24/2012US20120128767 Therapeutic calcium phosphate particles and methods of making and using same
05/24/2012US20120128760 Lipid compositions
05/24/2012US20120128752 Multi-phase microparticles and method of manufacturing multi-phase microparticles
05/24/2012US20120128741 Modified hyaluronic acid polymer compositions and related methods
05/24/2012US20120128731 Biocompatible carrier and method for fabricating the same
05/24/2012US20120128700 Constructs for delivery of therapeutic agents to neuronal cells
05/24/2012US20120128647 Delivery of compounds with rehydrated blood cells
05/24/2012US20120128595 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
05/24/2012US20120128581 Sincalide Formulations
05/24/2012CA2818583A1 Novel conjugates for targeted drug delivery
05/24/2012CA2816997A1 Novel polymer derivative of cytidine metabolic antagonist
05/23/2012EP2455104A1 Bio-functionalized stimulus-responsive dissolvable PEG-hydrogels
05/23/2012EP2455083A1 Pharmaceutical composition for dermal use comprising calcipotriol and a corticosteroid
05/23/2012EP2455074A1 Topical pharmaceutical compositions of flurbiprofen and methyl salicylate
05/23/2012EP2454286A1 Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities
05/23/2012EP2454271A2 Peptides whose uptake in cells is controllable
05/23/2012EP2453925A2 Cyclosporin conjugates
05/23/2012EP2453924A1 Improved conjugation method
05/23/2012EP2453923A2 Peptide-mediated non-covalent delivery of active agents across the blood brain barrier
05/23/2012EP2453919A1 Antibodies directed to gpnmb and uses thereof
05/23/2012EP2453908A2 Bifunctional stapled polypeptides and uses thereof
05/23/2012EP2453905A2 Methods and compositions for in vitro and in vivo chondrogenesis
05/23/2012EP2453892A1 Compounds and methods for the treatment of cancer
05/23/2012EP2453874A2 Methods for inhibiting yellow color and peroxide formation in a composition
05/23/2012EP2453873A1 Improvements in and relating to colon cleansing compositions
05/23/2012EP2081547B1 Galenic form for the trans-mucosal delivery of active ingredients
05/23/2012EP1806151B1 Drug for external use and adhesive patch
05/23/2012EP1761248B1 Carbohydrate-derivatized liposomes for targeting cellular carbohydrate recognition domains of ctl/ctld lectins, and intracellular delivery of therapeutically active compounds
05/23/2012EP1499329B2 Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass
05/23/2012EP1446418B1 Integrin targeting compounds
05/23/2012EP1412750B1 T1r2-t1r3 hetero-oligomeric sweet taste receptors and cell lines that express said receptors and use thereof for identification of sweet taste compounds
05/23/2012EP1346059B1 Photochemical internalization for delivery of molecules into the cytosol
05/23/2012EP1325014B1 Gamma-hydroxybutyrate compositions containing carbohydrate carriers
05/23/2012CN202223581U Spongy preparation releasing structure
05/23/2012CN1886427B Cellulose interpolymers and method of oxidation
05/23/2012CN1826138B Rg1 antibodies and uses thereof
05/23/2012CN1659288B Pharmaceutical composition for preventing or reducing DNA damage
1 ... 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 ... 1712